阿裏巴巴(09988.HK)發可持續發展債券淨籌約9.87億美元 悉數用於ESG項目
阿裏巴巴(09988.HK)表示,去年2月發行爲期20年專注可持續發展的債券截至今年1月,發債所得款項淨額約9.87億美元,已經悉數用以支持12個具有代表性的環境、社會及管治(ESG)相關項目,涵蓋綠色建築、能源效益、新冠疫情危機應對等領域。發債所得款項中有4.51億美元投入至能源效益項目,佔45.7%,3.52億美元投入至綠色建築項目,佔35.7%,1.47億美元用於新冠疫情危機應對項目,佔14.9%,其餘款項則用於可再生能源及循環經濟和設計項目。
能源效益項目方面,款項用於建設節能數據中心,以支持阿裏雲的相關舉措,並應用不同技術確保數據中心能在低耗能和低污染條件下運行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.